ABSTRAm. The chronically reserpine-treated rat, an experimental model for cystic fibrosis, exhibits generalized exocrinopathy, impaired pancreatic secretion, and decreased pancreatic amylase. Although chronic reserpine treatment induces malnutrition by decreasing food consumption and growth, the effects of this malnutrition per se on the exocrine pancreas have not been considered. In this study, the effects of chronic reserpine treatment and malnutrition on the exocrine pancreas were determined using pair-fed controls. Male, Sprague-Dawley rats were treated daily subcutaneously for 5 to 7 days with: I ) no injection (control), 2) 1.0 mllkg vehicle or sham (controlsham, pair fed-sham), or 3) 0.5 mglkg reserpine (chronically reserpine-treated). Both chronic reserpine-treatment and pair-feeding significantly decreased food consumption (40%), body weight (51 and 59%), total pancreatic amylase (49 and 56%) and specific amylase activity (62 and 61%), pancreatic protein (65 and 75%), and pancreatic weights (62 and 65%) compared to controls. These decreases, however, were comparable between the chronically reserpine-treated and pair fed-sham rats. In contrast, the secretory response to the biologicalls active cholecvstokinin analog cho~ec~stokinin octaieptidk was significantly attenuated in isolated oancreatic acini oreoared from reser~ine-
ANOVA, analysis of variance LSD, least significant difference CF is the most prevalent lethal genetic disease in the Caucasian race occumng in 1 :2000 live births. CF is an autosomal recessive disorder, but the exact nature and mechanism of the defect remains unknown. CF is characterized by chronic pulmonary disease and exocrine malfunction of the pancreas, sweat glands, salivary glands, and the mucus-producing glands of the gastrointestinal tract and respiratory system. It has been difficult to study the pancreatic defects in this disease because of the lack of available human tissue and the lack of an animal model. However, in 1975, Martinez and colleagues (1, 2) proposed the chronically reserpine-treated rat as an experimental animal model for CF. Reserpine-treated rats exhibit altered glycoprotein synthesis and secretion in the cells and ductus of salivary (1, 4) , tracheobronchial (5, 6), pancreatic exocrine glands (7) , and the intestine (8, 9) . In addition they manifest CF-like abnormalities in salivary gland secretions including alterations in volume, electrolyte, and total protein concentrations (2, 3, 10, l l ) , and they show morphological abnormalities in the pancreas (12, 14) , impaired pancreatic acinar secretion ( 13, 1 9 , and decreased pancreatic acinar amylase content (16) . These characteristics are similar to those in patients with CF.
The exact mechanisms by which chronic reserpine treatment exerts these effects are not known. Reserpine's depletion of catecholamine at nerve endings does not appear the cause of these effects (2) . Reserpine may act directly on the exocrine cell membrane or may exert a toxic effect on cellular metabolism which leads to alterations in enzyme synthesis, storage, or secretion (4, 17) . Reserpine treatment of colonic cells in vitro increases mucus production similarly to that seen with in vivo treatment (1 8) , supporting a direct cellular mechanism of reserpine action.
Although chronic reserpine treatment alters food consumption and growth in rats and mice, the effects of these alterations on the exocrine pancreas have not been considered (19, 20) . Decreased food consumption (malnutrition) or fasting in the rat also can result in decreased pancreatic amylase content (2 1, 25) . Consequently, this study was undertaken to determine the effects of malnutrition and chronic reserpine treatment on the rat exocrine pancreas using pair fed-sham controls.
MATERIALS AND METHODS
Male, Sprague-Dawley rats (1 00-180 g) were housed individually in hanging cages at 25 To measure pancreatic enzyme content, rats were killed on Reserpine 8.8 * 1.0' 0.57 + 0.04' 6.37 f 0.363" day 8 between 0900 and 1030 h. The Pancreata were removed *Values are mean + SEM of 8 rats. Rats were fed rat food, weightand frozen at -80" C. Pancreata were homogenized in phosphate-matched into groups and injected daily subcutaneously with 1) no buffered saline-1 % t~p s i n inhibitor and centrifuged at 16,000 x injection and fed ad libitum (C), 2) 1.0 ml/kg 2% propylene glycol-8% g, 4" C, 30 min. The supernatant was analyzed for amylase (E.C. ethanol-5% acetic acid and fed ad libitum (CS), 3) 0.5 mg/kg reserpine 3.2.1.1 ) by the Phadebas method using the Phadebas standard and fed ad libitum (reserpine), and 4) 1.0 ml/kg sham and fed the reference serum (261, for protein by the Lowry method using amount of food consumed by the reserpine-treated group (PFS). After 7 bovine serum albumin as the standard (271, for DNA by a days, rats were killed and pancreata removed. microfluorometric method (281, and for lipase (E.C. 3.1.
1.3) by
Oh'
Values for a given parameter not sharing a superscript are signifia titrimetric method (29) .
cantly different ( p < 0.001) by ANOVA and LSD. To determine pancreatic secretion, rats were killed on day 6 following an overnight fast. Fasting overnight reduced variability of secretion among rats; however, rats treated for 7 days with CRT PFS natant and cell pellets was assayed as described to obtain total TREATMENT A1iquOts acini were then Fig, 1 , Effects of chronic reserpine treatment on growth of rats, Rats incubated at 370 for 30 min with Or without various ' Once' -were fed rat food, weight-matched into groups, and treated daily subcutrations of C C K~ (30) . Amylase release during this incubation taneously with injections as follows: 1) C, no injection and fed ad libitum, was expressed as the percent of amylase in the 2) CS, 1.0 ml/kg 2% propylene glycol-8% ethanol-5% glacial acetic acid presence of CCKx 'Ompared the release in the absence of and fed ad lihitrrm, 3) CRT, 0.5 mg/kg reserpine and fed ad libillrm, and CCKx (control). 4 
RESULTS

6-
After 2 days, the CRT rats became hypodynamic and exhibited g 50 palpebral ptosis and diarrhea, while C and PFS rats exhibited x normal behavior. CRT and PFS rats consumed significantly ( p 2 4 0 < 0.001) less food (40%) than the C group (Table 1) . Pancreatic w weights significantly decreased ( p < 0.001) in the reserpine-30 treated (65%) and PFS (62%) rats (Table 1 ). The ratio of pancreatic weight to body weight significantly increased ( p < 0.001) g 20 only in the reserpine-treated rats. C and CS rats gained 44% of a:
initial body weight in 8 days while the CRT and PFS rats lost 26 10 and 20% of initial weight (Fig. 1 ). C and CS rats had significantly 2 ( p < 0.001) greater final weights than PFS (59%) and reserpinetreated (5 1 %) rats. Further, the final body weight of PFS rats was
significantly greater than that of reserpine-treated rats. TREATMENT Total pancreatic amylase-activity (U) decreased significantly Fig. 2 . Effects of chronic reserpine treatment on pancreatic enzymes.
(p < 0.05) in the reserpine-treated (49%) and PFS (56%) rats Rats were fed rat food, weight-matched into groups, and treated with compared to the C group (Fig. 2) . However, total amylase-activity daily injections subcutaneously as described in Figure I . Values are mean was comparable in the reserpine-treated and PFS rats. Specific + SEM of eight rats. "h'Values for a given parameter not sharing a amylase activity (U/mg pancreatic protein) also significantly superscript are significantly different (P < 0.05) by ANOVA and LSD.
H A Z L E T T ET AL. R e s e r~i n e 5 9 + 10" 81 rt 5' 210 + 21" *Values are m e a n + S E M of 8 rats. Rats were fed rat food, weightmatched into groups a n d injected daily subcutaneously as described in Table 1 . decreased ( p < 0.005) in the reserpine-treated (62%) and PFS (6 1 %) rats compared to the C group, but again was comparable between reserpine-treated and PFS rats ( Table 2) . Pancreatic protein also decreased comparably in the reserpine-treated (75%) and PFS (85%) rats. Pancreatic lipase was not altered by reserpine treatment or food restriction compared to C rats (Fig. 2) . DNA also was comparable among the four groups (Table 2) .
CCK% exerted a characteristic dose-de~endent effect on amvlase release in acini prepared from C, PFS, and reserpine-treatdd rats (Fig. 3) . Maximal stimulation of amylase release occurred at 3 x lo-'' M CCK, in all three groups. Higher concentrations of CCKx were less effective, exhibiting what has been termed a restricted stimulation. The magnitude of the stimulatory effect was greatest in the controls, intermediate in the PFS, and least in the reserpine-treated group. Further, there was a highly significant ( p < 0.0001, F2.67 = 28.629) effect of in vivo reserpine treatment on the secretory responsiveness of isolated acini as analyzed by 2-way ANOVA and LSD.
DISCUSSION
Reserpine-treatment of rats resulted in decreased food consumption as previously reported in neonatal rats (20) and adult mice (19) . The decreased food consumption resulted in lower body weights (19, 20) . In the present study, the decreased body weight cannot be attributed solely to decreased food consumption because the PFS rats lost less weight than the reserpinetreated rats despite comparable food intake. The 40% decrease in food consumption, 49% decrease in body weight, and the 39% decrease in pancreatic weight in reserpine-treated rats demonstrated that reserpine treatment induced malnutrition.
Pancreata were smaller in the reserpine-treated and PFS rats compared to C rats. However, pancreatic weight was greater relative to total body weight in the reserpine-treated rats. In contrast, Perlmuter and Martinez show a significant reduction in pancreas weight of reserpine-treated rats, but the ratio of pancreatic weight to body weight remains comparable to the C rats (15). Chung et al. (20) , however, report slightly higher pancreatic weights relative to body weight in reserpine-treated rat pups compared with controls. The higher pancreatic weight to body weight ratios suggest a relative sparing of the pancreas in reserpine-treatment.
Our results showed that chronic reserpine-treatment decreased rat pancreatic protein, amylase, and specific amylase activity. Similarly, Joehl and DeJoseph (1 6) show a significant decrease in the total amylase content of rat pancreatic acini isolated from CRT rats. However, these parameters were comparably decreased in the malnourished PFS rats in the present study. Other studies of malnutrition show either a ~arallel decrease in ~ancreatic enzymes (20) or a nonparallel iecrease in pancreat;~ amylase and an increase in pancreatic lipase (23, 24) . Pancreatic lipase, however, was not affected by either reserpine-treatment ormalnutrition (PFS) in this study resulting in a nonparallel change in pancreatic enzymes. The decreased amylase and total protein observed in both the reserpine-treated and PFS rats suggest that the reserpine-induced alterations in pancreatic enzyme content may be secondary to the malnutrition.
Despite the comparable decrease in amylase content in pancreata from PFS and CRT rats, the secretory response of these acini were distinctly different. CCKx-mediated amylase-release in acini prepared from PFS rats was significantly greater than the release by CRT acini and significantly less than C acini (Fig.  3) . Although chronic reserpine treatment caused a markedly attenuated secretory response over a wide concentration range of CCK,, it did not shift the dose-response curve. This attenuated responsiveness might be due either to a receptor or postreceptor defect. Irrespective of the underlying mechanisms, these data indicate that the alterations in secretory responsiveness resulting from malnutrition only partly account for those induced by reserpine.
Results from the present study suggest that chronic reserpine leads to a dual defect in the exocrine Dancreas. One defect can be attributed to the malnutrition induced by reserpine treatment, while the other is more directly related to the reserpine treatment. Therefore, studies using the reserpine-treated experimental model need to control for the induced malnutrition by using appropriate pair feeding.
